• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Tango Therapeutics (TNGX)

Common Shares
Sell: $17.09|Buy: $17.55|Change: 0.15 (0.87%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNScancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Address




Website

https://www.tangotx.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Tango Therapeutics Inc Fourth Quarter Earnings Results for 20262027-03-05T00:00:00
Tango Therapeutics Inc Annual Report for 20262027-03-05T00:00:00
Tango Therapeutics Inc Third Quarter Earnings Results for 20262026-11-04T09:00:00
Tango Therapeutics Inc Second Quarter Earnings Results for 20262026-08-05T00:00:00
Tango Therapeutics Inc Annual General Meeting for 20262026-06-05T09:00:00
Tango Therapeutics Inc First Quarter Earnings Results for 20262026-05-12T00:00:00
2026 Leerink Partners Global Healthcare Conference2026-03-11T15:00:00
Tango Therapeutics Inc Fourth Quarter Earnings Results for 20252026-03-05T00:00:00
Tango Therapeutics Inc Annual Report for 20252026-03-05T00:00:00
TD Cowen 46th Annual Health Care Conference2026-03-04T13:10:00

Previous key dates

NameKey Date
2026 Leerink Partners Global Healthcare Conference2026-03-11T15:00:00
Tango Therapeutics Inc Fourth Quarter Earnings Results for 20252026-03-05T00:00:00
Tango Therapeutics Inc Annual Report for 20252026-03-05T00:00:00
TD Cowen 46th Annual Health Care Conference2026-03-04T13:10:00
Guggenheim Emerging Outlook: Biotech Summit 20262026-02-12T14:00:00
44(th) Annual J.P. Morgan Healthcare Conference2026-01-14T12:45:00
Piper Sandler 37(th) Annual Healthcare Conference2025-12-03T13:30:00
2025 Jefferies Global Healthcare Conference2025-11-19T11:30:00
Tango Therapeutics Inc Third Quarter Earnings Results for 20252025-11-04T09:00:00
2025 Cantor Global Healthcare Conference2025-09-03T14:45:00
Tango Therapeutics Inc Second Quarter Earnings Results for 20252025-08-05T00:00:00
Goldman Sachs Annual Global Healthcare Conference2025-06-10T15:20:00
Tango Therapeutics Inc Annual General Meeting for 20252025-06-05T09:00:00
Tango Therapeutics Inc First Quarter Earnings Results for 20252025-05-12T00:00:00
Leerink's Global Healthcare Conference 20252025-03-12T14:20:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.